Chemoinformaics analysis of Diosgenin-3-O-beta-D-glucopyranoside
| Molecular Weight | 576.771 | nRot | 3 |
| Heavy Atom Molecular Weight | 524.355 | nRig | 36 |
| Exact Molecular Weight | 576.366 | nRing | 7 |
| Solubility: LogS | -4.233 | nHRing | 3 |
| Solubility: LogP | 3.615 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 93 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 96.1992 |
| nHD | 4 | BPOL | 59.1108 |
| QED | 0.377 |
| Synth | 5.725 |
| Natural Product Likeliness | 3.173 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.005 |
| HIA | 0.056 |
| CACO-2 | -4.845 |
| MDCK | 0.0000496 |
| BBB | 0.047 |
| PPB | 0.96951 |
| VDSS | 1.102 |
| FU | 0.0309596 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.334 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.835 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.085 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.516 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.146 |
| CL | 11.514 |
| T12 | 0.035 |
| hERG | 0.019 |
| Ames | 0.117 |
| ROA | 0.9 |
| SkinSen | 0.023 |
| Carcinogencity | 0.123 |
| EI | 0.005 |
| Respiratory | 0.361 |
| NR-Aromatase | 0.659 |
| Antiviral | No |
| Prediction | 0.621134 |